Summary of Significant Accounting Policies and Other Information (Tables)

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Concentration of Risk, by Risk Factor

The following table presents customers individually accounting for more than 10% of the Company’s net sales:

	For the Year Ended December 31,
	2025		2024
Customer B	20	%	11	%
Customer C	10	%	11	%
Customer E	10	%	**
Customer F	13	%	**

The following table presents customers individually accounting for more than 10% of the Company’s trade accounts receivable:

	As of December 31,
	2025		2024
Customer B	14	%	**
Customer C	10	%	**
Customer D	**		15	%
Customer E	11	%	**
Customer G	11	%	**

The following table presents suppliers individually accounting for more than 10% of the Company’s purchases:

	For the Year Ended December 31,
	2025		2024
Supplier A	21	%	16	%

**    Less than 10% of the total

Schedule of Inventory and Activity in Inventory Allowance

Inventories consist of the following:

(in thousands)	As of December 31,
Inventories	2025		2024
Raw materials	$	105,225	$	84,323
Work in process	5,103		872
Finished goods	25,288		16,812
Total inventories	135,616		102,007
Inventory allowance	(8,253)		(8,135)
Inventories, net	$	127,363	$	93,872

Activity in the Company’s inventory allowance was as follows:

(in thousands)	For the Year Ended December 31,
Inventory Allowance	2025		2024
Balance at beginning of period	$	8,135	$	5,730
Charged to expense	306		3,394
Write-offs	(188)		(989)
Balance at end of period	$	8,253	$	8,135

Schedule of Estimated Useful Lives by Type of Asset Category

Estimated useful lives by each type of asset category are as follows:

	Years
Buildings	Up to 39
Leasehold improvements	Lesser of (i) expected useful life of improvement or (ii) life of lease (including likely extension thereof)
Machinery and equipment	1 to 10

Property, plant and equipment by type were as follows:

(in thousands)	As of December 31,
Property, Plant and Equipment	2025		2024
Leasehold improvements	$	11,268	$	8,352
Machinery and equipment	53,306		48,643
Construction in progress	3,151		2,454
Total property, plant and equipment, at cost	67,725		59,449
Accumulated depreciation	(44,711)		(44,043)
Property, plant and equipment, net	$	23,014	$	15,406

Schedule of Other Accrued Liabilities

Other accrued liabilities consisted of the following:

(in thousands)	As of December 31,
Other Accrued Liabilities	2025		2024
Accrued product warranty	$	6,634	$	10,233
Accrued litigation 1	1,400		3,847
Contract liabilities	3,486		10,184
Accrued compensation and benefits	19,565		10,721
Accrued interest expense	268		1,237
Stock appreciation rights liability 2	1,070		1,804
Non-interest bearing note payable	740		693
Customs accrual	1,248		1,162
Taxes payable	257		200
Other	2,685		4,645
Total	$	37,353	$	44,726

1    As of December 31, 2025 and 2024, accrued litigation includes accruals related to various ongoing legal matters including associated legal fees. See Note 11. Commitments and Contingencies for further information regarding the various ongoing legal matters.

2    The Company has an incentive compensation plan, which authorizes the granting of a variety of different types of awards including, but not limited to, non-qualified stock options, incentive stock options, Stock Appreciation Rights (“SARs”), Restricted Stock Awards (“RSAs”), deferred stock and performance units to its executive officers, employees, consultants and Directors. The SAR awards granted for the year ended December 31, 2025 and 2024 were all liability classified awards and remained outstanding. See Note 14. Stock-Based Compensation for additional information on the SARs and RSAs.

Schedule of Accrued Product Warranty Activities

Accrued product warranty activities included in Other noncurrent liabilities on the Consolidated Balance Sheet are presented below:

(in thousands)	For the Year Ended December 31,
Accrued Product Warranty	2025		2024
Balance at beginning of year	$	13,972	$	19,263
Current year provision *	6,039		6,054
Changes in estimates for preexisting warranties **	829		1,239
Payments made during the period	(12,647)		(12,584)
Balance at end of year	8,193		13,972
Less: Current portion	6,634		10,233
Noncurrent accrued product warranty	$	1,559	$	3,739

*Warranty costs, net of supplier recoveries, and other adjustments, were $6.8 million and $6.5 million for the years ended December 31, 2025 and 2024, respectively. Supplier recoveries were $0.1 million and $0.8 million for the years ended December 31, 2025 and 2024, respectively.

**Changes in estimates for preexisting warranties reflect changes in the Company’s estimate of warranty costs for products sold in prior periods. Such adjustments typically occur when claims experience deviates from historical and expected trends. For the year December 31, 2025, the Company recorded a cost for changes in estimates of preexisting warranties of $0.8 million, or $0.04 per diluted share, and costs of $1.2 million, or $0.05 per diluted share, for the year ended December 31, 2024.